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Abstract: Experimental pregnancy was induced with gonadal steroids in in vivo ovariectomized rats. Conditions for premature
delivery were established by giving a salt-rich diet and administering oxytocin to induce high-risk pregnancy. In order to avoid early
delivery, a betamimetic ritodrine and the Ca++ channel blockers nitrendipine and nicardipine were administered to three separate
groups. The effects of these three tocolytic agents were examined by determining serum oestradiol and progesterone levels.
Additionally, systolic blood pressure was measured and tachycardia was observed.
After the administration of tocolytic agents, it was observed that serum oestradiol levels were increased while there was a decrease
in serum progesterone levels. These three drugs cause no difference in hormone levels and can be used as tocolytic agents; however,
it was observed that ritodrine carries the risk of tachycardia. Findings in the high-risk pregnancy group (hypertensive), to which no
tocolytic agent was given, showed that the normal pregnancy period had not been completed.
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Ritodrin ile Ca++ Kanal Blokerlerinin Tokolitik Etkilerinin Serum Estradiol ve Progesteron
Düzeyleri Üzerinden Karfl›laflt›r›lmas›
Özet: Bu çal›flmada in vivo ovariektomi yap›lan s›çanlara gonodal steroid uygulanarak deneysel gebelik oluflturuldu. Tuz diyeti ve
oksitosin uygulanarak riskli gebelik tablosu oluflturmak suretiyle erken do¤um ortam› haz›rland›. Erken do¤umu önlemek için bir
beta-mimetik olan ritodrin, Ca++ kanal blokerleri olan nitrendipin ve nikardipin üç ayr› gruba verildi. Bu üç tokolitik ajan›n etkileri
serum estradiol ve progesteron düzeyleri tayin edilerek incelendi. Ayr›ca sistolik bas›nç ve taflikardi de de¤erlendirildi.
Tokolitik ilaç kullanan her üç grupta da estradiol düzeylerinde art›fl, progesteron düzeylerinde düflüfl saptand›. Bu üç ilac›n tokolitik
etkili olarak kullan›labilece¤i, fakat ritodrinin taflikardi riski tafl›d›¤› gözlendi. Tokolitik ajan verilmemifl riskli gebelik grubunda
(hipertansif) saptanan bulgular bu grupta normal gebelik süresinin tamamlanmad›¤›n› gösterdi.
Anahtar Sözcükler: Ritodrin, Nikardipin, Nitrendipin, Estradiol, Progesteron, Gebelik

Introduction
In clinical trials tocolytic agents are used to prevent
premature delivery and control the pregnancy (1-9).
Several therapeutic attempts have been made to inhibit
uterine contractions, such as with alcohol, magnesium
sulphate, prostaglandin synthase inhibitors and betaadrenergic agonists (4-6,10,11). The use of betaadrenergic agonists, especially ritodrine, is associated
with several side effects, limiting their use (12,13). Side
effects such as hypertension, tachycardia and tremor have
stimulated investigators to search for new drugs (14).
Among the calcium channel blockers, verapamil and
nifedipine were used for the first time in the treatment of

premature labour (7). Nicardipine and nitrendipine, which
are newly synthesized calcium channel blockers, have
been seldom used as tocolytic agents. A few publications
report on their use in the management of preterm labour.
The tocolytic efficacy of these calcium antagonists or
other tocolytic agents depends on hormonal status,
especially concentrations of oestradiol and progesterone
in the extracellular fluid (15). In this study, experimental
pregnancy was induced by applying gonadal steroids in
normotensive and hypertensive rats. Tocolytic agents
were used to prolong pregnancy except in the
hypertensive group. Blood samples were collected and
serum concentrations of oestradiol and progesterone,
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systolic pressures and pulse rates were measured. The
aim of this study was to compare the tocolytic efficacy of
calcium channel blockers with less side effects and
ritodrine.

was also administered intraperitoneally from days 13 to
19 after ovariectomy. Blood samples were collected to
find out the tocolytic effect of nitrendipine on days 16,
18, 20 and 22 after ovariectomy. Serum samples were
analysed for the levels of oestradiol and progesterone.

Materials and Methods

Group 4: Rats were fed a salt-rich diet. They were
ovariectomized. Experimental pregnancy was induced.
Intraperitoneal injections of oxytocin were administered
from days 13 to 16 following ovariectomy. Nicardipine
was also administered intraperitonally for 7 days starting
from day 13 following ovariectomy. Blood samples were
collected to find out the tocolytic effect of nicardipine on
days 16, 18, 20 and 22 following ovariectomy. Serum
samples were analysed for the levels of oestradiol and
progesterone.

Ovariectomy and Experimental Pregnancy
Thirty adult female Wistar albino rats weighing 180230 g were used. Ovariectomy was performed on
nonpregnant rats under ether anaesthesia. Intraperitonal
injections of 200 µg/kg oestradiol benzoate from days 9
to 12 and a combination of 200 µg/kg oestradiol
benzoate and 20 mg/kg progesterone from the days 13
to 16 following ovariectomy were administered to the
rats to induce pregnancy. In addition, 2.5 IU oxytocin was
administered intraperitoneally to the rats from the days
13 to 16 following ovariectomy. The rats were fed a saltrich diet for 20 days before ovariectomy. The purpose of
this process was to induce premature labour associated
with hypertension.

The Groups and the Administration of Tocolytic
Agents
The rats were divided into five equal groups.
Group 1: Rats were fed a normal diet. They were
ovariectomized. No tocolytic agent or oxytocin was
administered. Experimental pregnancy was induced.
Blood samples were collected on days 16, 18, 20 and 22
following ovariectomy. Serum samples were analysed for
concentrations of oestradiol and progesterone.
Group 2: Rats were fed a salt-rich diet. They were
ovariectomized. Experimental pregnancy was induced.
Intraperitoneal injections of oxytocin were administered
for 4 days starting from day 13 following ovariectomy.
Ritodrine was also administered for 7 days starting from
day 13 following ovariectomy. Blood samples were
collected to find out the tocolytic effect of ritodrine on
days 16, 18, 20 and 22 following ovariectomy. Levels of
oestradiol and progesterone were analysed in the serum
samples.
Group 3: Rats were fed a salt-rich diet. They were
ovariectomized. Experimental pregnancy was induced.
Intraperitoneal injections of oxytocin were administered
from days 13 to 16 following ovariectomy. Nitrendipine
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Group 5: Rats were fed a salt-rich diet. They were
ovariectomized. Experimental pregnancy was induced.
Intraperitoneal injections of oxytocin were administered
for 4 days starting from day 13 following ovariectomy.
No tocolytic agent was administered. Blood samples were
collected on days 16, 18, 20 and 22 following
ovariectomy. Serum samples were analysed for the levels
of oestradiol and progesterone.
Measurement of Systolic Pressure
Hypertension was evaluated by attaching a tail-cuff to
the tail root of the rats fed a salt-rich diet. This process
was performed to measure the systolic pressure on days
1, 4, 7, 10, 13, 16, 19 and 22 following ovariectomy.
Measurement of Tachycardia
Tachycardia was evaluated by measuring pulse/min
with an EKG in ovariectomized rats on days 16, 20 and
22 following ovariectomy.
Collection of Blood Serum Samples
Blood samples (1.3 ml) were collected into tubes by
applying a tail-cut procedure on days 16, 18, 20 and 22
following ovariectomy. The serum was separated and
kept at –20 ºC until all samples were collected.
Measurement of Oestradiol and Progesterone
Levels
Serum was assayed for the levels of oestradiol using
an oestradiol radioimmunoassay kit (ICN-No. 07231102,
Oregon, New York, USA) and for the levels of
progesterone using a progesterone radioimmunoassay kit
(Amerlex-M No. 1657675, Amersham, UK). A Packard
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Multiprias 1 Model C.5301 gamma counter was used for
counting the radioimmunoassay samples.

Results
The groups in the study were as follows:

The protocol of this experimental study is depicted in
Table 1.

Group 1: Ovariectomized, pregnant. (control group)
Group 2: Ovariectomized, pregnant + oxytocin +
ritodrine + salt. (ritodrine group)

Statistical Procedure
SPSS for Windows Version 7.5 was used for analysis
of data. The results are given as mean and standard error
of the mean. Comparison of the results:

Group 3: Ovariectomized, pregnant + oxytocin +
nitrendipine + salt. (nitrendipine group)
Group 4: Ovariectomized, pregnant + oxytocin +
nicardipine + salt. (nicardipine group)

a. Paired t-test was used to compare differences
between groups.

Group 5: Ovariectomized, pregnant + oxytocin + salt.
(hypertensive group)

b. Mann-Whitney U test was used for non-parametric
analyses.

The means and standard errors of the means of
oestradiol levels (E2) (pg/ml) and progesterone levels (P)

p values less than 0.05 were considered statistically
significant.
Table 1.

The protocol of this experimental study.
DAYS

Procedure

Ovariectomy

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

21 22

1,
2,3,
4,5

1,
2,3,
4,5

1
2,3,
4,5

Oxytocin
25 I.U. I.P.

2,3, 2,3, 2,3, 2,3,
4,5 4,5 4,5 4,5

Ritodrine
2 mg/kg I.P.

2

2

2

2

2

2

2

Nitrendipine
2 mg/kg I.P.

3

3

3

3

3

3

3

Nicardipine
2 mg/kg I.P.

4

4

4

4

4

4

4

1, 1,
1, 1,
2,3, 2,3, 2,3, 2,3,
4,5 4,5 4,5 4,5

Oestradiol benzoate
200 mg/kg I.P.

1,
1,
1,
1,
2,3, 2,3, 2,3, 2,3,
4,5 4,5 4,5 4,5
1,
1,
1,
1,
2,3, 2,3, 2,3, 2,3,
4,5 4,5 4,5 4,5

Progesterone
20 mg/kg I.P.

1,
2,3,
4,5

Blood collection

Systolic pressure

20

2,3,
4,5

2,3,
4,5

Tachycardia

2,3,
4,5

2,3,
4,5

2,3,
4,5

2,3,
4,5
2,3,
4,5

1,
2,3,
4,5
2,3,
4,5

2,3,
4,5
2,3,
4,5

2,3,
4,5

1, 2, 3, 4 and 5 indicate the study groups .
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(ng/ml) of all groups are given in Tables 2 and 3. The
means and standard errors of the means of systolic
pressure values (mm/Hg) of the test animals are given in
Table 4. The means and standard errors of the means of
the test animals’ pulse rate on days 16, 20 and 22 are
given in Table 5.

The average gestational period in rats is 21 days. An
elevated concentration of oestradiol and a decreased
concentration of progesterone in the late period of
gestation cause an increase in the effect of oxytocin on
the uterus. Moreover, altered hormone levels indicate the
beginning of lactation before birth (19-23).

The differences between the groups daily and
between the levels of a group on different days were
statistically analysed.

In this study, pregnancy was completed in 18 days in
the hypertensive group, but in the other groups
pregnancy was completed in 22 days. This was in
accordance with the published findings about serum E2
and P levels in normal physiological pregnancies. Serum
E2 and P levels in the control group were in agreement
with the levels in the ritodrine, nitrendipine and
nicardipine groups. These findings confirm the effects of
ritodrine, nitrendipine and nicardipine as known tocolytic
agents on pregnancy. When a comparison was made
statistically between the control group and the test
groups, insignificant differences were found (Table 2). In
these groups, E2 levels were the same as normal
physiological pregnancy values (45-60 pg/ml). The
significant difference between the control group and the
hypertensive group may indicate that increased E2 levels

Discussion
Numerous studies have assessed the relationship
between the tocolytic activities of calcium channel
blockers and hormonal changes. Several reports have
suggested that tocolysis with nifedipine was more
pronounced in the pregnant uterus than in the
nonpregnant uterus in the management of uterine
contraction (16-18). However, the tocolytic effect of
nifedipine was not different in uterus of rats treated with
oestradiol only or with a combination of oestradiol and
progesterone (9,16).

Table 2.

Mean E2 levels on days 16, 18, 20 and 22 in all groups.

Groups

n

1

6

Day 16
X ± S.E.

Day 18
X ± S.E.

20.11 ± 0.51

Day 20
X ± S.E.

30.45 ± 0.99
a

Day 22
X ± S.E.

43.40 ± 0.60
a

49.00 ± 0.74

2

6

22.12 ± .0.72

33.41 ± 0.44

42.51 ± 0.36

3

6

24.92 ± 0.41a,b

35.87 ± 0.17a,b

43.75 ± 1.13

50.24 ± 0.47
51.26 ± 0.75

4

6

24.73 ± 0.70a,b

30.01 ± 0.96b,c

44.72 ± 0.75a

48.34 ± 0.69b,c

5

6

33.64 ± 0.19a,b,c,d

47.50 ± 1.64a,b,c,d

69.96 ± 0.96a,b,c,d

81.82 ± 0.48a,b,c,d

Significant difference (p < 0.05), a compared with Group 1, b compared with Group 2, c compared with Group 3 and d compared with Group 4.

Table 3.

Mean P levels on days 16, 18, 20 and 22 in all groups.

Groups

n

1

6

80.50 ± 0.37

78.10 ± 0.85

67.30 ± 1.18

52.40 ± 0.37

2

6

71.50 ± .0.37a

67.30 ± 1.37a

60.90 ± 0.74a

52.50 ± 1.19

3

6

73.40 ± 0.49a,b

70.50 ± 0.90a

62.70 ± 0.71a

49.04 ± 0.77a,b

4
5

6
6

Day 16
X ± S.E.

Day 18
X ± S.E.

a,b,c

69.50 ± 0.88

a,b,c,d

60.00 ± 0.77

Day 20
X ± S.E.

a

70.30 ± 0.52

a,b,c,d

52.20 ± 0.89

Day 22
X ± S.E.

b,c

50.10 ± 1.20a,b

a,b,c,d

32.40 ± 0.25a,b,c,d

65.50 ± 0.42
41.00 ± 1.23

Significant difference (p < 0.05), a compared with Group 1, b compared with Group 2, c compared with Group 3 and d compared with Group 4.
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Table 4.

Mean systolic pressures (mm/Hg) in the experimental animals from days 1 to 20.

Groups

n

Day 16
X ± S.E.

Day 18
X ± S.E.

2

6

110.1 ± 1.84

166.0 ± 2.36

140.3 ± 0.73

127.3 ± 0.87

3

6

111.6 ± 1.50

170.6 ± 0.69a

130.0 ± 2.87a

122.1 ± 0.72a

4

6

100.0 ± 1.17a,b

156.3 ± 1.09a,b

141.1 ± 1.34b

123.0 ± 0.70a,b

5

6

110.3 ± 1.17c

166.3 ± 0.87a,b,c

174.3 ± 1.87a,b,c

186.5 ± 1.30a,b,c

Groups

n

Day 16
X ± S.E.

Day 18
X ± S.E.

Day 20
X ± S.E.

Day 22
X ± S.E.

2

6

110.3 ± 1.83

121.0 ± 1.02

130.3 ± 1.17

130.3 ± 0.93

3

6

122.5 ± 0.84

130.0 ± 1.33

131.0 ± 0.97

127.0 ± 1.17

4

6

117.5 ± 0.20

134.6 ± 0.50

130.0 ± 1.26

131.1 ± 1.34

5

6

110.3 ± 1.17

119.6 ± 1.19

135.3 ± 1.74

184.6 ± 1.32

Day 20
X ± S.E.

Day 22
X ± S.E.

Significant difference (p < 0.05), a compared with Group 2, b compared with Group 3, c compared with Group 4.

Table 5.
Groups

n

Day 16
X ± S.E.

2

6

227.5 ± 0.51

280.5 ± 1.46

280.0 ± 1.20

3

6

237.5 ± 0.73a

224.5 ± 1.21a

241.0 ± 1.39a

4

6

230.5 ± 1.42a,b

226.0 ± 0.94

241.5 ± 1.19

5

6

207.1 ± 1.32a,b,c

226.8 ± 2.37a

244.5 ± 0.99a,b,c

Significant difference (p < 0.05),
compared with Group 4.

a

Day 20
X ± S.E.

compared with Group 2,

Day 22
X ± S.E.

b

compared with Group 3,

in the hypertensive group were due to the lactation after
the pregnancy ending on day 18. There was no difference
between the control group and the ritodrine group in
terms of progesterone levels. There was a statistical
difference between the control group and the
nitrendipine and nicardipine groups (Table 3), but the
values obtained were the same as the normal
physiological pregnancy values.
The results of the statistical comparison of E2 and P
levels in the groups according to the days confirmed the
pregnancy (p < 0.001). In all groups E2 levels increased
gradually from days 16 to 22 , while there was a gradual
decrease in P levels on the same days (Tables 2, 3). In the
hypertensive group on day 16 the E2 level (X = 33.64)
was higher and the P level (X = 60.00) was lower than in
the other groups. This situation seems to be normal,
because the control group and the groups given the

The mean levels of pulse rate on
days 16, 20 and 22 in the
experimental groups.

c

tocolytic agent had no risk during pregnancy.
Tocolytic agents were administered to the groups
from days 13 to 19, except for the hypertensive and
control groups, to prevent preterm labour. After the
administration the results obtained showed that the
control group, which represents the normal pregnancy
model, was in agreement with the ritodrine, nitrendipine
and nicardipine groups, but was different from the
hypertensive group. These data indicated that tocolytic
agents prolong the pregnancy. The results from the
hypertensive group were different from those of the
other groups, as expected, because this group has a high
risk during pregnancy.
In the groups fed a salt-rich diet, systolic pressure
values were measured on days 1, 4, 7, 10, 13, 16, 19
and 20. In all groups, systolic pressure values increased
until day 13. After day 13, in the ritodrine, nicardipine
421
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and nitrendipine groups systolic pressure was controlled
due to the administration of the tocolytic agent (Table 4).
However, in the hypertensive group the elevation of
systolic pressure continued until day 20, showing that
there was hypertension in this group. The normal
pressure value of rats is approximately 110 mm/Hg (24).
The pulses per minute were measured in order to
determine tachycardia on days 16, 20 and 22 (Table 5).
The pulse rate per minute in rats was 220 (25). In the
nitrendipine group and the nicardipine group given
tocolytic drugs, pulse rates on day 20 confirmed that
there was no tachycardia. Pulse rates in the groups on
day 22 (X = 241.0 in the nitrendipine group, X = 241.5
in the nicardipine group) were slightly higher, but these

values were lower than those in the ritodrine group (X =
280.0) on day 22. The high pulse rates determined on
day 20 in the group given ritodrine continued until day
22. This result shows that one of the side effects of
ritodrine is tachycardia.
In this study, in vivo pregnancy was induced by the
administration of oestradiol and progesterone in
ovariectomized rats. The use of calcium channel blockers
and ritodrine as a tocolytic agent prolonged pregnancy in
animals fed a salt-rich diet. Finally, the administration of
calcium channel blockers and ritodrine appears to be the
treatment of choice in cases of premature labour and
hypertension.
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